Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Lilly to debut Tempo personalized diabetes management platform in U.S. 

By Brian Buntz | November 7, 2022

Tempo platform

[Image courtesy of Lilly]

Eli Lilly (NYSE:LLY) has announced that it would commercialize its Tempo personalized diabetes management platform in the U.S. before the end of 2022. The company anticipates full nationwide availability of the platform in 2023.

Designed for adults with type 1 and 2 diabetes, the platform includes the Tempo Smart Button, a compatible app, and the Tempo Pen prefilled insulin pen. The Bluetooth-enabled smart button provides the app with custom insulin dose data. Lilly bills the technology as a ‘personalized diabetes management platform.’

The reusable Smart Button is a medical device that works with the company’s disposable insulin pens that won FDA approval in 2019 and 2020.

Indianapolis-based Lilly notes patients using the platform can make data-driven decisions to manage diabetes. In particular, the platform is designed to enable data sharing between adults with diabetes and healthcare providers.

The Tempo platform enables patients to receive medication reminders, educational resources and feedback on blood glucose levels.

“Lilly has over a century of knowledge of insulin and its complexities and recognizes the emotional impact of managing diabetes,” said Kevin Cammack, head of connected care at Lilly Diabetes, in a news release. “Launching this platform is an opportunity for us to more broadly support those who rely on our insulins.”

FDA cleared the Smart Button on September 16.

Lilly collaborated with Welldoc on the development of the companion app.

Lilly has worked with Dexcom (NSDQ:DXCM), Glooko, myDiabby Healthcare (Bordeaux, France) and Roche when developing the Smart Button. Lilly’s Tempo technology has compatibility with these companies’ apps outside of the United States.

In the U.S., the Tempo technology can also sync data from several manufacturers of wearable devices, including Fitbit, Garmin and Google Fit, and the Apple Health app.

The company’s shares ticked up 1.84% to $363.87 in afternoon trading.

So far this year, Lilly’s share price is up 33.91%.

The Tempo Smart Button also won CE marking on August 10.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE